Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 81

Sort by

Sort Order Select

Journal Articles

Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Tanvi H. Patel, Ramya Bachu, Trilok Shrivastava, Jawad Alrawabdeh, Marah Alzubi, Jael Hastings, Harold Dean, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Guido Tricot, Fenghuang Zhan, John D Shaughnessy, Jr, Frits van Rhee, Samer Al Hadidi

Blood (2023) 142 (Supplement 1): 6764.

https://doi.org/10.1182/blood-2023-180964

Published: 2023

Journal Articles

Total Therapy (TT)-4: A Phase 3 Trial Comparing L-TT4 and S-TT4 and Tandem Auto Transplants in Standard Risk Multiple Myeloma

Samer Al Hadidi, Obada Ababneh, Carson W Ercanbrack, Carolina Schinke, Sharmilan Thanendrarajan, Clyde Bailey, Robert Smith, Susan Panozzo, Guido Tricot, Daisy V. Alapat, John D Shaughnessy, Jr, Fenghuang Zhan, Bart Barlogie, Maurizio Zangari, Frits van Rhee

Blood (2023) 142 (Supplement 1): 3594.

https://doi.org/10.1182/blood-2023-181034

Published: 2023

Journal Articles

The BCMA-Targeted Fourth-Generation CAR-T Cells Secreting CST6 Against Multiple Myeloma and Suppresses Osteolytic Lesions

Fumou Sun, Yan Cheng, Jin-Ran Chen, Visanu Wanchai, David E. Mery, Hongwei Xu, Dongzheng Gai, Samer Al Hadidi, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, John D Shaughnessy, Jr, Guido Tricot, Fenghuang Zhan

Blood (2023) 142 (Supplement 1): 452.

https://doi.org/10.1182/blood-2023-181853

Published: 2023

Journal Articles

A 5-Stage System for ASCT Multiple Myeloma

Wancheng Guo, David E. Mery, Eric Siegel, Fumou Sun, Yan Cheng, Visanu Wanchai, Cody Ashby, Clyde Bailey, Daisy V. Alapat, Hongling Peng, Samer Al Hadidi, Sharmilan Thanendrarajan, Carolina Schinke, Maurizio Zangari, Frits van Rhee, Guido Tricot, John D Shaughnessy, Jr, Fenghuang Zhan

Blood (2023) 142 (Supplement 1): 3331.

https://doi.org/10.1182/blood-2023-181117

Published: 2023

Journal Articles

Sequential Imaging with Diffusion-Weighted Whole-Body MRI (DW-MRI) and PET-CT Identifies Patients at High Risk of Relapse in Multiple Myeloma

Carolina Schinke, Leo Rasche, Cody Ashby, Rudy van Hemert, Sharmilan Thanendrarajan, Samer Al Hadidi, Maurizio Zangari, Clyde Bailey, Daisy V. Alapat, John D Shaughnessy, Jr, Fenghuang Zhan, Bart Barlogie, Frits van Rhee, Niels Weinhold

Blood (2023) 142 (Supplement 1): 882.

https://doi.org/10.1182/blood-2023-180896

Published: 2023

Journal Articles

Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study

Blood (2023) 142 (Supplement 1): 545.

https://doi.org/10.1182/blood-2023-174875

Published: 2023

Journal Articles

Trial in Progress: A Phase 1 Study of KTX-1001, an Oral, First-in-Class, Selective MMSET Inhibitor in Patients with Relapsed and Refractory Multiple Myeloma

Blood (2023) 142 (Supplement 1): 3391.

https://doi.org/10.1182/blood-2023-174550

Published: 2023

Journal Articles

Prognostic Value of Ferritin in ASCT MM Patients: Integration with GEP Models and ISS Series Systems

Wancheng Guo, David E. Mery, Eric Siegel, Fumou Sun, Yan Cheng, Cody Ashby, Daisy V. Alapat, Hongling Peng, Samer Al Hadidi, Sharmilan Thanendrarajan, Carolina Schinke, Maurizio Zangari, Frits van Rhee, Guido Tricot, John D Shaughnessy, Jr, Fenghuang Zhan

Blood (2023) 142 (Supplement 1): 6573.

https://doi.org/10.1182/blood-2023-181254

Published: 2023

Journal Articles

The Effect of Stem Cell Infusion on Immune Effector Cell Associated Hematotoxicity with BCMA CAR T in Multiple Myeloma

Blood (2023) 142 (Supplement 1): 758.

https://doi.org/10.1182/blood-2023-186697

Published: 2023

Journal Articles

Variability of Definition of High-Risk Multiple Myeloma in Phase III Clinical Trials

Faris Jamal Abu Za'nouneh, Obada Ababneh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D Shaughnessy, Jr., Fenghuang Zhan, Frits van Rhee, Samer Al Hadidi

Blood (2022) 140 (Supplement 1): 10116–10117.

https://doi.org/10.1182/blood-2022-158188

Published: 2022

Journal Articles

Clinical Research Focused on Supportive Care in Multiple Myeloma: A Cross Sectional Analysis

Hadeel Al-Zawahreh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Fenghuang Zhan, John D Shaughnessy, Jr., Frits van Rhee, Samer Al Hadidi

Blood (2022) 140 (Supplement 1): 13240–13241.

https://doi.org/10.1182/blood-2022-159652

Published: 2022

Journal Articles

Clinical Outcome of Patients with Relapsed Refractory Multiple Myeloma Listed for BCMA Directed Commercial CAR T Therapy

Blood (2022) 140 (Supplement 1): 8038–8039.

https://doi.org/10.1182/blood-2022-168794

Published: 2022

Journal Articles

Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant

Nishanth Thalambedu, Yetunde Ogunsesan, Jaskirat Sethi, Munawwar Hussain, Lakshmi Yarlagadda, Sravani Gundarlapalli, Horace J. Spencer, Clyde Bailey, Samer Al Hadidi, Sharmilan Thanendrarajan, Maurizio Zangari, John D. Shaughnessy, Jr., Fenghuang Zhan, Juan Carlos Rico Crescencio, Frits van Rhee, Carolina Schinke

Blood (2022) 140 (Supplement 1): 12922–12923.

https://doi.org/10.1182/blood-2022-169353

Published: 2022

Journal Articles

Risk of Infections Associated with the Use of Bispecific Antibodies in Multiple Myeloma: A Pooled Analysis

Farah Mazahreh, Liyan Mazahreh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D Shaughnessy, Jr., Fenghuang Zhan, Frits van Rhee, Samer Al Hadidi

Blood (2022) 140 (Supplement 1): 4378.

https://doi.org/10.1182/blood-2022-157858

Published: 2022

Journal Articles

A 12 Gene Signature Accurately Predicts Multiple Myeloma Progression from Monoclonal Gammopathy of Undetermined Significance

Blood (2022) 140 (Supplement 1): 264–265.

https://doi.org/10.1182/blood-2022-163654

Published: 2022

Journal Articles

Under-Representation of Black Patients with Multiple Myeloma in Studies Supporting International Myeloma Working Group Guidelines

Suhib Fahmawi, Carolina Schinke, Maurizio Zangari, Sharmilan Thanendrarajan, John D Shaughnessy, Jr., Fenghuang Zhan, Frits van Rhee, Samer Al Hadidi

Blood (2022) 140 (Supplement 1): 13212–13213.

https://doi.org/10.1182/blood-2022-158346

Published: 2022

Journal Articles

Parameters Influencing Count Recovery Post Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Yetunde Ogunsesan, Reid D. Landes, Jaskirat Sethi, Munawwar Hussain, Nishanth Thalambedu, Lakshmi Yarlagadda, Sravani Gundarlapalli, Clyde Bailey, Samer Al Hadidi, Sharmilan Thanendrarajan, Maurizio Zangari, John D. Shaughnessy, Jr., Fenghuang Zhan, Frits van Rhee, Carolina Schinke

Blood (2022) 140 (Supplement 1): 10579–10580.

https://doi.org/10.1182/blood-2022-167624

Published: 2022

Journal Articles

The Use and Reporting of Cytogenetics in Phase III Multiple Myeloma Clinical Trials

Obada Ababneh, Faris Jamal Abu Za'nouneh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D Shaughnessy, Jr., Fenghuang Zhan, Frits van Rhee, Samer Al Hadidi

Blood (2022) 140 (Supplement 1): 12532–12533.

https://doi.org/10.1182/blood-2022-158282

Published: 2022

Journal Articles

Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance

Naveen K Yarlagadda, Meera Mohan, Shebli Atrash, Sravani Gundarlapalli, Shadiqul Hoque, Sunil Kakadia, Sharmilan Thanendrarajan, Carolina Schinke, Daisy Alapat, Guido Tricot, Erming Tian, Jeffery R. Sawyer, Fenghuang Zhan, Frits van Rhee, Maurizio Zangari

Blood (2021) 138 (Supplement 1): 2713.

https://doi.org/10.1182/blood-2021-148228

Published: 2021

Journal Articles

Ethnic Disparities in AL Amyloidosis Outcomes Among Hospitalized Patients in the United States

Samer Al Hadidi, Deepa Dongarwar, Hamisu Salihu, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee

Blood (2021) 138 (Supplement 1): 4110.

https://doi.org/10.1182/blood-2021-147060

Published: 2021

NARROW

Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Total Therapy (TT)-4: A Phase 3 Trial Comparing L-TT4 and S-TT4 and Tandem Auto Transplants in Standard Risk Multiple Myeloma

The BCMA-Targeted Fourth-Generation CAR-T Cells Secreting CST6 Against Multiple Myeloma and Suppresses Osteolytic Lesions

A 5-Stage System for ASCT Multiple Myeloma

Sequential Imaging with Diffusion-Weighted Whole-Body MRI (DW-MRI) and PET-CT Identifies Patients at High Risk of Relapse in Multiple Myeloma

Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study

Trial in Progress: A Phase 1 Study of KTX-1001, an Oral, First-in-Class, Selective MMSET Inhibitor in Patients with Relapsed and Refractory Multiple Myeloma

Prognostic Value of Ferritin in ASCT MM Patients: Integration with GEP Models and ISS Series Systems

The Effect of Stem Cell Infusion on Immune Effector Cell Associated Hematotoxicity with BCMA CAR T in Multiple Myeloma

Variability of Definition of High-Risk Multiple Myeloma in Phase III Clinical Trials

Clinical Research Focused on Supportive Care in Multiple Myeloma: A Cross Sectional Analysis

Clinical Outcome of Patients with Relapsed Refractory Multiple Myeloma Listed for BCMA Directed Commercial CAR T Therapy

Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant

Risk of Infections Associated with the Use of Bispecific Antibodies in Multiple Myeloma: A Pooled Analysis

A 12 Gene Signature Accurately Predicts Multiple Myeloma Progression from Monoclonal Gammopathy of Undetermined Significance

Under-Representation of Black Patients with Multiple Myeloma in Studies Supporting International Myeloma Working Group Guidelines

Parameters Influencing Count Recovery Post Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

The Use and Reporting of Cytogenetics in Phase III Multiple Myeloma Clinical Trials

Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance

Ethnic Disparities in AL Amyloidosis Outcomes Among Hospitalized Patients in the United States

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only